146 related articles for article (PubMed ID: 9753062)
1. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles.
Molldrem JJ; Jiang YZ; Stetler-Stevenson M; Mavroudis D; Hensel N; Barrett AJ
Br J Haematol; 1998 Sep; 102(5):1314-22. PubMed ID: 9753062
[TBL] [Abstract][Full Text] [Related]
2. In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin.
Laver J; Castro-Malaspina H; Kernan NA; Levick J; Evans RL; O'Reilly RJ; Moore MA
Br J Haematol; 1988 Aug; 69(4):545-50. PubMed ID: 3136795
[TBL] [Abstract][Full Text] [Related]
3. Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia.
Killick SB; Marsh JC; Gordon-Smith EC; Sorlin L; Gibson FM
Br J Haematol; 2000 Mar; 108(3):582-91. PubMed ID: 10759717
[TBL] [Abstract][Full Text] [Related]
4. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
[TBL] [Abstract][Full Text] [Related]
5. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression.
Kochenderfer JN; Kobayashi S; Wieder ED; Su C; Molldrem JJ
Blood; 2002 Nov; 100(10):3639-45. PubMed ID: 12393644
[TBL] [Abstract][Full Text] [Related]
6. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
[TBL] [Abstract][Full Text] [Related]
7. Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.
Aivado M; Rong A; Stadler M; Germing U; Giagounidis A; Strupp C; Novotny J; Josten KM; Kobbe G; Hildebrandt B; Gattermann N; Aul C; Haas R; Ganser A
Eur J Haematol; 2002 Apr; 68(4):210-6. PubMed ID: 12071936
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antithymocyte globulin for human bone marrow transplantation. Antihematopoietic and immunosuppressive activity.
Harada M; Gale RP
Transplantation; 1982 Jun; 33(6):625-30. PubMed ID: 7048664
[TBL] [Abstract][Full Text] [Related]
9. Comparable TNF-alpha, IFN-gamma and GM-CSF production by purified normal marrow CD3 cells in response to horse anti-lymphocyte and rabbit antithymocyte globulin.
Piaggio G; Podestá M; Pitto A; Pittaluga GB; Isaza A; Benvenuto F; Bruno B; Bacigalupo A
Eur J Haematol; 1998 Apr; 60(4):240-4. PubMed ID: 9579877
[TBL] [Abstract][Full Text] [Related]
10. Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin.
Amare M; Abdou NL; Robinson MG; Abdou NI
Am J Hematol; 1978; 5(1):25-32. PubMed ID: 311583
[TBL] [Abstract][Full Text] [Related]
11. The effects of antithymocyte globulin on natural killer cells.
Neudorf S; Jones M
Exp Hematol; 1988 Nov; 16(10):831-5. PubMed ID: 3139435
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism.
Teramura M; Kobayashi S; Iwabe K; Yoshinaga K; Mizoguchi H
Br J Haematol; 1997 Jan; 96(1):80-4. PubMed ID: 9012691
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anaemia.
Platanias L; Gascon P; Bielory L; Griffith P; Nienhuis A; Young N
Br J Haematol; 1987 Aug; 66(4):437-43. PubMed ID: 3117088
[TBL] [Abstract][Full Text] [Related]
14. Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
Haller MJ; Gitelman SE; Gottlieb PA; Michels AW; Perry DJ; Schultz AR; Hulme MA; Shuster JJ; Zou B; Wasserfall CH; Posgai AL; Mathews CE; Brusko TM; Atkinson MA; Schatz DA
Diabetes; 2016 Dec; 65(12):3765-3775. PubMed ID: 27669730
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
Stadler M; Germing U; Kliche KO; Josten KM; Kuse R; Hofmann WK; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe HH; Heimpel H; Aul C; Ganser A
Leukemia; 2004 Mar; 18(3):460-5. PubMed ID: 14712285
[TBL] [Abstract][Full Text] [Related]
16. Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.
Duléry R; Mohty M; Duhamel A; Robin M; Beguin Y; Michallet M; Vigouroux S; Lioure B; Garnier A; El Cheikh J; Bulabois CE; Huynh A; Bay JO; Daguindau E; Ceballos P; Clément L; Dauriac C; Maillard N; Legrand F; Cornillon J; Guillerm G; François S; Lapusan S; Chevallier P; Damaj G; Yakoub-Agha I
Biol Blood Marrow Transplant; 2014 May; 20(5):646-54. PubMed ID: 24462982
[TBL] [Abstract][Full Text] [Related]
17. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2.
Burdach S; Shatsky M; Wagenhorst B; Levitt L
J Immunol; 1987 Jul; 139(2):452-8. PubMed ID: 3110272
[TBL] [Abstract][Full Text] [Related]
18. [Immunosuppressive treatment of the myelodysplastic syndrome].
Larsen MS; Hasselbalch HC
Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: correlation with in vitro erythroid culture studies.
Mangan KF; Shadduck RK
Am J Hematol; 1984; 17(4):417-26. PubMed ID: 6238526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
